Cargando…

Predicting a local recurrence after breast-conserving therapy by gene expression profiling

INTRODUCTION: To tailor local treatment in breast cancer patients there is a need for predicting ipsilateral recurrences after breast-conserving therapy. After adequate treatment (excision with free margins and radiotherapy), young age and incompletely excised extensive intraductal component are pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuyten, Dimitry SA, Kreike, Bas, Hart, Augustinus AM, Chi, Jen-Tsan Ashley, Sneddon, Julie B, Wessels, Lodewyk FA, Peterse, Hans J, Bartelink, Harry, Brown, Patrick O, Chang, Howard Y, van de Vijver, Marc J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779489/ https://www.ncbi.nlm.nih.gov/pubmed/17069664 http://dx.doi.org/10.1186/bcr1614

Ejemplares similares

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

Classification of ductal carcinoma in situ by gene expression profiling
por: Hannemann, Juliane, et al.
Publicado: (2006)

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

Gene Expression Programs of Human Smooth Muscle Cells: Tissue-Specific Differentiation and Prognostic Significance in Breast Cancers
por: Chi, Jen-Tsan, et al.
Publicado: (2007)

Lymph node metastases display gene expression profiles of their primary breast carcinomas
por: Weigelt, B, et al.
Publicado: (2005)

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
por: Bijker, N, et al.
Publicado: (2001)

A scale-space method for detecting recurrent DNA copy number changes with analytical false discovery rate control
por: van Dyk, Ewald, et al.
Publicado: (2013)

Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer
por: Buess, Martin, et al.
Publicado: (2007)

Reproducibility of molecular portraits in early stage breast cancer
por: Nuyten, DSA, et al.
Publicado: (2005)

The diagnosis and management of pre-invasive breast disease: Pathological diagnosis – problems with existing classifications
por: Van de Vijver, Marc J, et al.
Publicado: (2003)

Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability
por: van Vliet, Martin H, et al.
Publicado: (2008)

No common denominator for breast cancer lymph node metastasis
por: Weigelt, B, et al.
Publicado: (2005)

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
por: Liu, Gang, et al.
Publicado: (2009)

Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers
por: Chi, Jen-Tsan, et al.
Publicado: (2006)

Constitutive nuclear lamina–genome interactions are highly conserved and associated with A/T-rich sequence
por: Meuleman, Wouter, et al.
Publicado: (2013)

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
por: Vossen, David M., et al.
Publicado: (2019)

SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets
por: Lai, Carmen, et al.
Publicado: (2007)

Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets
por: Farazi, Thalia A, et al.
Publicado: (2014)

Integration of Clinical and Gene Expression Data Has a Synergetic Effect on Predicting Breast Cancer Outcome
por: van Vliet, Martin H., et al.
Publicado: (2012)

RUBIC identifies driver genes by detecting recurrent DNA copy number breaks
por: van Dyk, Ewald, et al.
Publicado: (2016)

A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets
por: Lai, Carmen, et al.
Publicado: (2006)

Knowledge driven decomposition of tumor expression profiles
por: van Vliet, Martin H, et al.
Publicado: (2009)

DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.
por: Beerman, H., et al.
Publicado: (1991)

Expression profiling predicts outcome in breast cancer
por: van 't Veer, Laura J, et al.
Publicado: (2003)

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS
por: Bijker, N, et al.
Publicado: (2002)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Hepatic Colic from Gallstones, with Recurrent Jaundice
por: Sneddon, William
Publicado: (1876)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS-mutant colorectal cancer
por: Šuštić, Tonći, et al.
Publicado: (2019)

Flexible co‐data learning for high‐dimensional prediction
por: van Nee, Mirrelijn M., et al.
Publicado: (2021)

Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials
por: van der Hage, Jos A, et al.
Publicado: (2011)

Systems of conservation laws 1: hyperbolicity, entropies, shock waves
por: Serre, Denis, et al.
Publicado: (1999)

Metazoan stringent-like response mediated by MESH1 phenotypic conservation via distinct mechanisms
por: Mestre, Alexander A., et al.
Publicado: (2022)

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
por: Faneyte, I F, et al.
Publicado: (2003)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
por: Vollebergh, Marieke A, et al.
Publicado: (2014)

Analysis of mass spectrometry data using sub-spectra
por: Meuleman, Wouter, et al.
Publicado: (2009)

Targeting the RB-E2F pathway in breast cancer
por: Johnson, Jackie, et al.
Publicado: (2016)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

Determination of Stromal Signatures in Breast Carcinoma
por: West, Robert B, et al.
Publicado: (2005)

KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data
por: de Ronde, Jorma J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tgd6q5lri1c7tg6ou72imhcfr1